Anavex Life Sciences
AVXL
#8098
Rank
HK$2.19 B
Marketcap
HK$23.71
Share price
-2.42%
Change (1 day)
-62.03%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): -HK$4.21

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -HK$4.23. a decrease over its 2024 EPS that were of -HK$4.08.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025-HK$4.233.85%
2024-HK$4.08-13.33%
2023-HK$4.70-3.23%
2022-HK$4.8614.81%
2021-HK$4.2320%
2020-HK$3.53-16.67%
2019-HK$4.2338.46%
2018-HK$3.0618.18%
2017-HK$2.59-21.43%
2016-HK$3.29-35.38%
2015-HK$5.09-36.27%
2014-HK$7.99112.5%
2013-HK$3.76-58.62%
2012-HK$9.09-0%
2011-HK$9.09-29.27%
2010-HK$12.8551.85%
2009-HK$8.46-0%
2008-HK$8.46237.5%
2007-HK$2.51
2006N/A-100%
2005-HK$0.31499.97%
2004-HK$0.05225

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
HK$49.37-1,266.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
HK$7.37-274.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$234.32 5,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-HK$0.39-90.74%๐Ÿ‡บ๐Ÿ‡ธ USA